Hypoplastic Myelodysplastic Syndrome: A Real-World Case Series of Outcomes with Cyclosporine and Eltrombopag
- 10 November 2026
- journal article
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- MDS-504 Mutation Profiling and Characteristics of Hypoplastic MDSClinical Lymphoma Myeloma and Leukemia, 2022
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic NeoplasmsLeukemia, 2022
- Hypocellular myelodysplastic syndromes (h-MDS): from clinical description to immunological characterization in the Italian multi-center experienceLeukemia, 2022
- Eltrombopag Added to Immunosuppression in Severe Aplastic AnemiaNew England Journal of Medicine, 2022
- Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndromeLeukemia, 2019